Next-generation sequencing-based BRCA testing on cytological specimens from ovarian cancer ascites reveals high concordance with tumour tissue analysis.
Caterina FumagalliAlessandra RappaChiara CasadioIlaria BetellaNicoletta ColomboMassimo BarberisElena Guerini-RoccoPublished in: Journal of clinical pathology (2019)
BRCA test may be performed on ovarian cancer ascites, reproducing BRCA1/2 tumour status and representing a useful tool for clinical decision-making.